how do cryptocurrencies have value Top See results about

[In November, the global sales of pure electric and plug-in hybrid vehicles exceeded 1.8 million, with China accounting for 70%. According to the data released by market research company Rho Motion on Friday, the global sales of pure electric and plug-in hybrid vehicles increased for the seventh consecutive month in November, with a year-on-year increase of 32.3%, reaching 1.83 million, the third consecutive month reaching a record high. Among them, the sales of pure electric and plug-in hybrid vehicles in China market increased by 50%, reaching 1.27 million vehicles, accounting for nearly 70% of the total global sales.Yuejiang: It is planned to sell about 40 million H shares globally through the IPO of Hong Kong stocks. It is expected to be listed on the Hong Kong Stock Exchange on December 23, and Yuejiang announced on the Hong Kong Stock Exchange on December 13 that the company plans to sell about 40 million H shares globally, with Hong Kong public offering accounting for 5% and international offering accounting for 95%. The offer price will not be higher than HK$ 20.80 per offering share, and it is currently expected to be not lower than HK$ 18.80 per offering share, with 200 shares per lot. It is expected that the shares will start trading on the Stock Exchange at 9: 00 am on Monday, December 23, 2024, Hong Kong time.People's Daily: Ensure that artificial intelligence is always a "friend". At present, the ability of artificial intelligence is comparable to that of human brain in many aspects, but it cannot accurately distinguish right from wrong in terms of value. This means that it is necessary to strengthen the supervision and regulation of artificial intelligence from many aspects. In recent years, many countries, including China, have introduced artificial intelligence development plans, management methods and supervision principles, precisely to ensure that technology truly serves people and benefits society. No matter how far artificial intelligence develops, it all comes from human design and is an extension of human wisdom. Artificial intelligence is doing more and more work and becoming more and more intelligent. We must take precautions to ensure that it is always a "friend".

Du Zhaocai, former deputy director of the State Sports General Administration, will be sentenced in the first instance today. Today, Du Zhaocai, former deputy director of the State Sports General Administration, will be sentenced in the Wuhan Intermediate People's Court.Yuejiang: It is planned to sell about 40 million H shares globally through the IPO of Hong Kong stocks. It is expected to be listed on the Hong Kong Stock Exchange on December 23, and Yuejiang announced on the Hong Kong Stock Exchange on December 13 that the company plans to sell about 40 million H shares globally, with Hong Kong public offering accounting for 5% and international offering accounting for 95%. The offer price will not be higher than HK$ 20.80 per offering share, and it is currently expected to be not lower than HK$ 18.80 per offering share, with 200 shares per lot. It is expected that the shares will start trading on the Stock Exchange at 9: 00 am on Monday, December 23, 2024, Hong Kong time.Media Office in the Gaza Strip: The Israeli army bombed the Nuseilet refugee camp, killing 33 people. According to Palestinian media, from the evening of 12th to the early morning of 13th local time, the Israeli army attacked the central and southern parts of the Gaza Strip, causing a lot of casualties. According to the Gaza Media Office, 33 people were killed and 84 others were missing or injured in the Israeli bombing of Nuseilet refugee camp in central Gaza on the evening of 12th. The Palestinian newspaper Al-Quds reported that Israeli troops bombed a tent for displaced people in Khan Younis, a city in southern Gaza, early on the 13th, killing two people and injuring many others.

Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Guotai Junan: The rise of leading enterprises and the downward shift of costs are important features of the steel industry entering a new cycle. Guotai Junan issued a document saying that with the change of demand structure, the demand for plates has steadily increased, and the demand for high-end plates such as automobiles, household appliances, shipbuilding, offshore engineering and energy is strong. The added value and profit per ton of products brought by leading companies' active adjustment of product structure, accumulation of products, R&D drive, continuous capital expenditure and equipment investment have been significantly improved, gradually widening the gap with the industry average gross profit. When the industry is facing the marginal losses of most steel enterprises, leading companies still maintain a high profit level by relying on the cost advantages brought by product differences and management, and the rise and differentiation of industry leaders are emerging. On the other hand, with the gradual increase in the supply side and the difficulty in improving the demand side, iron ore has gradually entered a loose cycle, and the steel cost constraints are expected to gradually improve.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.